December 31, 2024 · Form 4 insider transaction
Renninger Robert bought 12,359 shares of Athira Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.